Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Arrhythmias

Free Subscription Articles published in Eur Heart J Retrieve available abstracts of 273 articles: HTML format

Single Articles

February 2026
1. SELLAL JM, Dib N, Karakachoff M, McLeod CJ, et al
   Arrhythmias in congenitally corrected transposition of the great arteries: an international study.
   Eur Heart J. 2026;47:831-838.
   PubMed     Abstract available
   
   
   
2. WALDMANN V, Duthoit G, Pasquie JL, Champ-Rigot L, et al
   Catheter ablation in congenital heart diseases: a French nationwide study.
   Eur Heart J. 2026;47:816-827.
   PubMed     Abstract available
   
   
   
3. GALLI M, Patrono C
   Weekly Journal Scan: Long-term antithrombotic therapy for patients with atrial fibrillation and drug-eluting stents: primum non nocere.
   Eur Heart J. 2026 Feb 18:ehag062. doi: 10.1093.
   PubMed    
   
   
   
4. ROSSI FB, Sammarco A, Seccia TM
   Potassium and aldosterone as determinants of new-onset atrial fibrillation.
   Eur Heart J. 2026 Feb 13:ehag057. doi: 10.1093.
   PubMed    
   
   
   
5. HESSELLUND AK, Svendsen JH, Diederichsen SZ
   Hypokalaemia and atrial fibrillation: a data-driven perspective.
   Eur Heart J. 2026 Feb 13:ehag058. doi: 10.1093.
   PubMed    
   
   
   
6. CREA F
   Focus on trials: atrial fibrillation, heart failure with reduced ejection fraction, acute coronary syndrome, ischaemic stroke, and renovascular hypertension.
   Eur Heart J. 2026;47:649-654.
   PubMed    
   
   
   
7. CAI L, Wan H, Sun Y, Middeldorp ME, et al
   Atrial fibrillation: an underappreciated complication of diabetes.
   Eur Heart J. 2026 Feb 11:ehag044. doi: 10.1093.
   PubMed     Abstract available
   
   
   
8. SEPEHRI SHAMLOO A, Dagres N
   Subcutaneous implantable cardioverter-defibrillators enter maturity: HONEST lessons from a nationwide cohort.
   Eur Heart J. 2026 Feb 9:ehaf1094. doi: 10.1093/eurheartj/ehaf1094.
   PubMed    
   
   
   
9. MIGLIORE F, Ottaviano L, Priori SG
   Programming optimization is crucial for minimizing inappropriate shocks in patients with Brugada syndrome with a subcutaneous implantable cardioverter-defibrillator.
   Eur Heart J. 2026 Feb 6:ehag007. doi: 10.1093.
   PubMed    
   
   
   
10. BERGONTI M, Conte G
    Sex differences in atrial fibrillation-related atrial remodelling: the end of the debate?
    Eur Heart J. 2026 Feb 4:ehag045. doi: 10.1093.
    PubMed    
    
    
    January 2026
11. RAVEENDRA K, Nadarajah R, Larvin H, Farooq M, et al
    Non-antiarrhythmic pharmacotherapy in cardio-renal-metabolic disease and incident atrial fibrillation: a trial meta-analysis.
    Eur Heart J. 2026 Jan 28:ehag021. doi: 10.1093.
    PubMed     Abstract available
    
    
    
12. JAIS P, Neuzil P, Scherr D, Frison E, et al
    Pulsed field vs radiofrequency ablation for paroxysmal atrial fibrillation: the BEAT PAROX-AF trial.
    Eur Heart J. 2026 Jan 22:ehaf1115. doi: 10.1093/eurheartj/ehaf1115.
    PubMed     Abstract available
    
    
    
13. MYRSTAD M
    A broken heart: 100 years since the first diagnosis of atrial fibrillation in an athlete.
    Eur Heart J. 2026 Jan 12:ehaf859. doi: 10.1093.
    PubMed    
    
    
    
14. LOWRES N, Orchard JJ, Freedman B
    Digital heartbeat: wearables for early detection and integrated management of atrial fibrillation.
    Eur Heart J. 2026 Jan 8:ehaf998. doi: 10.1093.
    PubMed    
    
    
    
15. XIE D, Liang D, Zhou L, Liu Y, et al
    Cardiac endogenous transmitter system: molecular features, functions, and clinical implications.
    Eur Heart J. 2026;47:188-198.
    PubMed     Abstract available
    
    
    
16. FINOCCHIARO G, Zorzi A, Abela M, Baggish A, et al
    Abnormal electrocardiogram findings in athletes.
    Eur Heart J. 2026;47:152-169.
    PubMed     Abstract available
    
    
    
17. CREA F
    Focus on arrhythmias: cardiac endogenous transmitter systems, atrial fibrillation, and short QT and Brugada syndromes.
    Eur Heart J. 2026;47:139-144.
    PubMed    
    
    
    
18. PERETTO G, Merlo M, Ambrosi A, Bacigalupi E, et al
    Major arrhythmias in non-dilated left ventricular cardiomyopathy: a novel prediction score.
    Eur Heart J. 2026;47:94-106.
    PubMed     Abstract available
    
    
    December 2025
19. JOHNSON R, Fletcher RA, Peters S, Ohanian M, et al
    Titin-related familial dilated cardiomyopathy: factors associated with disease onset.
    Eur Heart J. 2025;46:5240-5257.
    PubMed     Abstract available
    
    
    
20. KERKOURI F, Marquie C, Boveda S, Anselme F, et al
    Long-term outcomes of subcutaneous implantable cardioverter defibrillators: the French nationwide HONEST study.
    Eur Heart J. 2025 Dec 19:ehaf918. doi: 10.1093.
    PubMed     Abstract available
    
    
    
21. MATHIJSSEN H, Bawaskar PH, Shenoy C
    Cardiovascular magnetic resonance phenotyping in cardiac sarcoidosis: simplicity is indeed the ultimate sophistication for primary prevention implantable cardioverter-defibrillator decisions.
    Eur Heart J. 2025 Dec 19:ehaf1027. doi: 10.1093/eurheartj/ehaf1027.
    PubMed    
    
    
    
22. CREA F
    Focus on the many facets of atrial fibrillation: from prediction to treatment.
    Eur Heart J. 2025;46:5101-5105.
    PubMed    
    
    
    
23. KARAKASIS P, Antoniadis AP, Fragakis N
    Atrial remodeling in persistent atrial fibrillation: Energy source or lesion set?
    Eur Heart J. 2025 Dec 12:ehaf914. doi: 10.1093.
    PubMed    
    
    
    
24. MACRAE CA
    Genetic testing in cardiology: insights into 'overlap' from atrial fibrillation.
    Eur Heart J. 2025 Dec 12:ehaf988. doi: 10.1093.
    PubMed    
    
    
    November 2025
25. OZKARTAL T, Bergonti M, Conte G
    Trouble shooting for unexpected bradycardia after atrial leadless pacemaker implantation.
    Eur Heart J. 2025 Nov 28:ehaf986. doi: 10.1093.
    PubMed    
    
    
    
26. MYHRE PL, Hoff NJS, Lund LH
    Potential role of repeated Valsalva manoeuvres in atrial fibrillation risk among elite rowers.
    Eur Heart J. 2025 Nov 28:ehaf969. doi: 10.1093.
    PubMed    
    
    
    
27. LA GERCHE A, Spencer LW, Myrstad M, Flannery DM, et al
    Maybe Valsalva, but please consider big hearts in middle-aged athletes as an explanation for atrial fibrillation prevalence.
    Eur Heart J. 2025 Nov 28:ehaf970. doi: 10.1093.
    PubMed    
    
    
    
28. SCHNABEL RB, Rienstra M
    Integrated care: a pathway to successful atrial fibrillation catheter ablation.
    Eur Heart J. 2025 Nov 25:ehaf938. doi: 10.1093.
    PubMed    
    
    
    
29. HAMDANI N, Akin I, El-Battrawy I
    Gene-therapy in inherited channelopathies like short-QT syndrome: a robust direction towards precision medicine.
    Eur Heart J. 2025 Nov 20:ehaf831. doi: 10.1093.
    PubMed    
    
    
    
30. BINDING C, Elmegaard M, Larsen S, Boysen EK, et al
    Temporal trends in the use of oral anticoagulants and clinical outcomes in older, elderly, and very elderly patients with atrial fibrillation: a Danish nationwide study.
    Eur Heart J. 2025 Nov 18:ehaf877. doi: 10.1093.
    PubMed     Abstract available
    
    
    
31. DUNCKER D, Marijon E, Metra M, Piot O, et al
    Sudden cardiac death in newly diagnosed non-ischaemic or ischaemic cardiomyopathy assessed with a wearable cardioverter-defibrillator: the German nationwide SCD-PROTECT study.
    Eur Heart J. 2025;46:4597-4606.
    PubMed     Abstract available
    
    
    
32. SHAMLOO AS, Di Biase L, Arya A
    Clinical consensus statement on epicardial ventricular arrhythmia ablation: key messages.
    Eur Heart J. 2025 Nov 11:ehaf741. doi: 10.1093.
    PubMed    
    
    
    
33. NATTEL S
    Left-atrial low-voltage areas and sex: mechanisms and insights into sex-related differences in atrial fibrillation susceptibility.
    Eur Heart J. 2025 Nov 11:ehaf767. doi: 10.1093.
    PubMed    
    
    
    
34. BAYKANER T, Butler J
    Managing atrial fibrillation-mediated cardiomyopathy: the causality-consequence conundrum.
    Eur Heart J. 2025 Nov 11:ehaf764. doi: 10.1093.
    PubMed    
    
    
    
35. MERINO JL, Reiffel JA, Camm AJ
    EHRA practical compendium of antiarrhythmic drugs: 10 key messages on contemporary use.
    Eur Heart J. 2025 Nov 7:ehaf805. doi: 10.1093.
    PubMed    
    
    
    
36. CREA F
    Focus on trials: primary prevention, ischaemic heart disease, atrial fibrillation, and obstructive sleep apnoea.
    Eur Heart J. 2025;46:4347-4350.
    PubMed    
    
    
    
37. SCHUBERT MR, Sinner MF
    Understanding atrial cardiomyopathy: a missing link in the prevention of atrial fibrillation, heart failure, and stroke?
    Eur Heart J. 2025 Nov 6:ehaf832. doi: 10.1093.
    PubMed    
    
    
    
38. ZHOU F, Li J, Lu M
    From myocarditis to arrhythmogenic right ventricular cardiomyopathy: a diagnostic odyssey in a young male with recurrent chest symptoms.
    Eur Heart J. 2025 Nov 6:ehaf864. doi: 10.1093.
    PubMed    
    
    
    October 2025
39. LAWS JL, Shabani M, Williams HL, Grauherr DD, et al
    Genetic evaluation of early-onset atrial fibrillation: impact on patient management.
    Eur Heart J. 2025 Oct 30:ehaf829. doi: 10.1093.
    PubMed     Abstract available
    
    
    
40. LI Q, Lv TT, Zhang P
    Implantable cardioverter-defibrillator for primary prevention in children and adolescents with long QT syndrome: rethinking the boundaries.
    Eur Heart J. 2025 Oct 23:ehaf807. doi: 10.1093.
    PubMed    
    
    
    
41. VAD OB, van Vreeswijk N, Yassin AS, Blaauw Y, et al
    Atrial cardiomyopathy: markers and outcomes.
    Eur Heart J. 2025 Oct 15:ehaf793. doi: 10.1093.
    PubMed     Abstract available
    
    
    
42. GIAMMARINO L, Odening KE
    Towards a personalized, mechanism-based risk prediction of post-operative atrial fibrillation.
    Eur Heart J. 2025 Oct 14:ehaf731. doi: 10.1093.
    PubMed    
    
    
    
43. REINSTADLER SJ, Schreinlechner M, Bauer A
    Digital screening for atrial fibrillation to prevent stroke: the Austrian Digital Heart Program.
    Eur Heart J. 2025 Oct 3:ehaf714. doi: 10.1093.
    PubMed    
    
    
    September 2025
44. NAKASHIMA K, Yamaguchi T, Takahashi Y, Otsubo T, et al
    Sex differences in atrial fibrillation-related atrial remodelling assessed by electroanatomic mapping and biopsy.
    Eur Heart J. 2025 Sep 25:ehaf768. doi: 10.1093.
    PubMed     Abstract available
    
    
    
45. MATHIJSSEN H, Bawaskar PH, Shenoy C
    Cardiovascular magnetic resonance phenotyping: the new standard for primary prevention implantable cardioverter-defibrillator decision-making in cardiac sarcoidosis.
    Eur Heart J. 2025 Sep 25:ehaf759. doi: 10.1093.
    PubMed    
    
    
    
46. POYHONEN P, Kandolin R, Kupari M
    Cardiovascular magnetic resonance in the assessment of the risk of fatal or life-threatening ventricular arrhythmias in suspected vs diagnosed cardiac sarcoidosis.
    Eur Heart J. 2025 Sep 25:ehaf758. doi: 10.1093.
    PubMed    
    
    
    
47. KELTERS IR, Koop Y, Young ME, Daiber A, et al
    Circadian rhythms in cardiovascular disease.
    Eur Heart J. 2025;46:3532-3545.
    PubMed     Abstract available
    
    
    
48. JASTRZEBSKI M, Kielbasa G, Cano O, Curila K, et al
    Left bundle branch area pacing vs right ventricular pacing for atrioventricular block: the MELOS RELOADED study.
    Eur Heart J. 2025 Sep 22:ehaf699. doi: 10.1093.
    PubMed     Abstract available
    
    
    
49. AGUILAR M, Macle L, Ditac G, Benali K, et al
    Atrial fibrillation burden is underestimated by non-invasive monitoring: the CIRCA-DOSE trial.
    Eur Heart J. 2025 Sep 16:ehaf647. doi: 10.1093.
    PubMed    
    
    
    
50. WHINNETT Z, Naraen A, Vijayaraman P, Cleland JGF, et al
    Physiological pacing: mechanisms, clinical indications, and perspectives.
    Eur Heart J. 2025;46:3407-3419.
    PubMed     Abstract available
    
    
    
51. ZENG Z, Wang X, Pei J, Wang P, et al
    Endothelial plasticity in atrial fibrosis by integrating single-cell sequencing and genetic lineage tracing.
    Eur Heart J. 2025;46:3470-3482.
    PubMed     Abstract available
    
    
    
52. CHRISTENSEN AH, Pan G, Marvig RL, Rodriguez Gonzalez FG, et al
    Gain-of-function enhancer variant near KCNB1 causes familial ST-depression syndrome.
    Eur Heart J. 2025;46:3486-3497.
    PubMed     Abstract available
    
    
    
53. GOETTE A
    Not all atrial fibrillations are born equal: the impact of chronobiology.
    Eur Heart J. 2025 Sep 15:ehaf582. doi: 10.1093.
    PubMed    
    
    
    
54. FAKUADE FE, Gronwald J, Brandes P, Doring Y, et al
    Cytosolic calcium handling signature: integration with clinical predictors enhances prediction of post-operative atrial fibrillation.
    Eur Heart J. 2025 Sep 9:ehaf609. doi: 10.1093.
    PubMed     Abstract available
    
    
    
55. YUAN X, Ju F, Wu H, Zhao Y, et al
    Surgical left atrial appendage occlusion in valvular heart disease without atrial fibrillation: the OPINION trial.
    Eur Heart J. 2025 Sep 1:ehaf674. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2025
56. NIMANI S, Bains S, Alerni N, Ordog B, et al
    AAV9-mediated KCNH2 suppression-replacement gene therapy in a transgenic rabbit model of type 1 short QT syndrome.
    Eur Heart J. 2025 Aug 30:ehaf660. doi: 10.1093.
    PubMed     Abstract available
    
    
    
57. LINZ D, Chaldoupi SM
    Hypokalaemia in atrial fibrillation: a red flag for more comprehensive workup?
    Eur Heart J. 2025 Aug 30:ehaf651. doi: 10.1093.
    PubMed    
    
    
    
58. HESSELLUND AK, Kongebro EK, Haugan KJ, Graff C, et al
    Hypokalaemia and atrial fibrillation detected by implanted loop recorders.
    Eur Heart J. 2025 Aug 30:ehaf623. doi: 10.1093.
    PubMed     Abstract available
    
    
    
59. VERMEER J, Vinck-de Greef T, van den Broek M, de Louw B, et al
    Improving outcomes of atrial fibrillation ablation by integrated personalized lifestyle interventions: a randomized controlled trial.
    Eur Heart J. 2025 Aug 30:ehaf689. doi: 10.1093.
    PubMed     Abstract available
    
    
    
60. SABA L
    Cerebral signatures of cardiovascular disease: distinct brain lesion patterns in atrial fibrillation and atherosclerosis.
    Eur Heart J. 2025 Aug 29:ehaf551. doi: 10.1093.
    PubMed    
    
    
    
61. SEGAN L, Kistler PM, Nanayakkara S, Taylor A, et al
    Catheter ablation vs rate control in atrial fibrillation with left ventricular systolic dysfunction and fibrosis: the CAMERA-MRI II trial.
    Eur Heart J. 2025 Aug 29:ehaf604. doi: 10.1093.
    PubMed    
    
    
    
62. STEGMANN T, Joundi RA, Srivastava A, Sinnecker T, et al
    Atrial fibrillation and atherosclerosis cause different vascular brain lesions on magnetic resonance imaging.
    Eur Heart J. 2025 Aug 29:ehaf550. doi: 10.1093.
    PubMed     Abstract available
    
    
    
63. MORA-AYESTARAN N, Ochoa JP, Gomez-Gonzalez C, Navarro-Penalver M, et al
    Arrhythmic genotypes in dilated cardiomyopathy and risk of advanced heart failure.
    Eur Heart J. 2025 Aug 29:ehaf605. doi: 10.1093.
    PubMed     Abstract available
    
    
    
64. SVENNBERG E, Freedman B, Andrade JG, Anselmino M, et al
    Recent-onset atrial fibrillation: challenges and opportunities.
    Eur Heart J. 2025 Aug 28:ehaf478. doi: 10.1093.
    PubMed     Abstract available
    
    
    
65. SEGAN L, Kistler PM, Nanayakkara S, Taylor A, et al
    Withdrawal of heart failure therapy after atrial fibrillation rhythm control with ejection fraction normalization: the WITHDRAW-AF trial.
    Eur Heart J. 2025 Aug 12:ehaf563. doi: 10.1093.
    PubMed     Abstract available
    
    
    
66. CHAO TF, Kuo L
    Intermittent left bundle branch block in a patient with cardiac sarcoidosis.
    Eur Heart J. 2025 Aug 7:ehaf172. doi: 10.1093.
    PubMed    
    
    
    
67. ANDRADE JG, Macle L
    Is atrial remodelling after atrial fibrillation catheter ablation clinically relevant?
    Eur Heart J. 2025 Aug 6:ehaf557. doi: 10.1093.
    PubMed    
    
    
    
68. GUASCH E, Mont L
    Atrial fibrillation in elite rowers: a genetic and endurance sport nexus?
    Eur Heart J. 2025 Aug 1:ehaf410. doi: 10.1093.
    PubMed    
    
    
    
69. TEN CATE H, Ten Berg J
    Fibrin clot lysis predicts anticoagulant-associated bleeding in atrial fibrillation: ready for clinical use?
    Eur Heart J. 2025 Aug 1:ehaf458. doi: 10.1093.
    PubMed    
    
    
    July 2025
70. PEDERSEN JJ, Kuhl JT, Elming MB, Pham MHC, et al
    Epicardial adipose tissue and new-onset atrial fibrillation in a Danish cohort.
    Eur Heart J. 2025 Jul 31:ehaf515. doi: 10.1093.
    PubMed    
    
    
    
71. MIYAMOTO K, Kanaoka K, Yodogawa K, Fujimoto Y, et al
    Cryoballoon vs radiofrequency ablation in persistent atrial fibrillation: the CRRF-PeAF trial.
    Eur Heart J. 2025 Jul 24:ehaf451. doi: 10.1093.
    PubMed     Abstract available
    
    
    
72. NIELSEN-KUDSK JE, Boersma LVA, Camm AJ
    Left atrial appendage closure: a reappraisal of atrial fibrillation guidelines.
    Eur Heart J. 2025 Jul 15:ehaf454. doi: 10.1093.
    PubMed    
    
    
    
73. OBERGASSEL J, Suling A, Borof K, Camm AJ, et al
    Short-term benefit of early rhythm control for atrial fibrillation: the EAST-AFNET 4 trial.
    Eur Heart J. 2025 Jul 10:ehaf397. doi: 10.1093.
    PubMed    
    
    
    
74. SCHWARTZ PJ, Spazzolini C
    Are long QT syndrome patients managed differently in different countries?
    Eur Heart J. 2025 Jul 9:ehaf394. doi: 10.1093.
    PubMed    
    
    
    
75. LUXAN G, Sossalla S
    Endothelial plasticity and fibrosis in atrial fibrillation: reframing the therapeutic landscape for targeted interventions.
    Eur Heart J. 2025 Jul 8:ehaf428. doi: 10.1093.
    PubMed    
    
    
    
76. 
    Correction to: 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): Developed by the task force for the management of atrial fibrillation of the Eur
    Eur Heart J. 2025 Jul 7:ehaf306. doi: 10.1093.
    PubMed    
    
    
    
77. 
    Correction to: Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study.
    Eur Heart J. 2025 Jul 3:ehaf434. doi: 10.1093.
    PubMed    
    
    
    
78. LIPPERT L, Burkard T, Markel F, Debus V, et al
    Long QT syndrome in children and adolescents: risk factors and outcomes in a large German cohort.
    Eur Heart J. 2025 Jul 2:ehaf365. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2025
79. FLANNERY MD, Canovas R, Janssens K, Mitchell AM, et al
    Atrial fibrillation in former world-class rowers: role of environmental and genetic factors.
    Eur Heart J. 2025 Jun 25:ehaf369. doi: 10.1093.
    PubMed     Abstract available
    
    
    
80. SPONA DC, Haugan KJ, Graff C, Hojberg S, et al
    Circadian patterns of atrial fibrillation and disease progression assessed by implanted loop recorders.
    Eur Heart J. 2025 Jun 16:ehaf386. doi: 10.1093.
    PubMed     Abstract available
    
    
    
81. LINDE C, Packer M, Bauersachs J
    Great debate: ablation of atrial fibrillation should be performed in patients with heart failure with reduced ejection fraction.
    Eur Heart J. 2025 Jun 10:ehaf182. doi: 10.1093.
    PubMed    
    
    
    
82. SALEEM-TALIB S, Hoevenaars CPR, Molitor N, van Driel VJ, et al
    Leadless pacing: a comprehensive review.
    Eur Heart J. 2025;46:1979-1990.
    PubMed     Abstract available
    
    
    May 2025
83. PARKER WAE, Nelson TA, Lee J, Judge HM, et al
    Pre-treatment lysis time of plasma-derived fibrin clots and bleeding in patients on oral anticoagulants for atrial fibrillation in the ARISTOTLE trial.
    Eur Heart J. 2025 May 30:ehaf347. doi: 10.1093.
    PubMed     Abstract available
    
    
    
84. MATHIJSSEN H, Bawaskar PH, Rochlani Y, Georgy I, et al
    Prediction of ventricular arrhythmic outcomes in suspected cardiac sarcoidosis: a comparison of cardiovascular magnetic resonance phenotyping vs. societal recommendations for implantable cardioverter-defibrillator placement.
    Eur Heart J. 2025 May 22:ehaf338. doi: 10.1093.
    PubMed     Abstract available
    
    
    
85. SHINZATO K, Takahashi Y, Yamaguchi T, Otsubo T, et al
    Atrial amyloidosis identified by biopsy in atrial fibrillation: prevalence and clinical presentation.
    Eur Heart J. 2025 May 20:ehaf332. doi: 10.1093.
    PubMed     Abstract available
    
    
    
86. WANG J, Verkerk AO, Wilders R, Zhang Y, et al
    SCN10A-short gene therapy to restore conduction and protect against malignant cardiac arrhythmias.
    Eur Heart J. 2025;46:1747-1762.
    PubMed     Abstract available
    
    
    
87. NOUBIAP JJ, Dewland TA, Montenegro GC, Oo HH, et al
    Illicit stimulants and ventricular arrhythmias: a longitudinal cohort study.
    Eur Heart J. 2025 May 7:ehaf282. doi: 10.1093.
    PubMed     Abstract available
    
    
    
88. CREA F
    Key topics: sex-related differences in vascular surgery; atrial fibrillation and cognitive performance; and gene therapy of ventricular arrhythmias.
    Eur Heart J. 2025;46:1689-1692.
    PubMed    
    
    
    
89. CLAUSS S, Nahrendorf M, Kaab S
    Leducq-funded programme: immune targets for the treatment of atrial fibrillation.
    Eur Heart J. 2025 May 6:ehaf176. doi: 10.1093.
    PubMed    
    
    
    
90. KALMAN JM, Saad E, Gerstenfeld EP
    Knowledge gaps in the 2024 consensus statement on atrial fibrillation ablation.
    Eur Heart J. 2025 May 6:ehaf175. doi: 10.1093.
    PubMed    
    
    
    April 2025
91. LODIN K, Da Silva CO, Wang Gottlieb A, Bulatovic I, et al
    Mitral annular disjunction and mitral valve prolapse: long-term risk of ventricular arrhythmias after surgery.
    Eur Heart J. 2025 Apr 15:ehaf195. doi: 10.1093.
    PubMed     Abstract available
    
    
    
92. ZHANG D
    Cholinergic control of cardiac electrical conduction and ventricular arrhythmia: endogenous or exogenous?
    Eur Heart J. 2025 Apr 9:ehaf011. doi: 10.1093.
    PubMed    
    
    
    
93. CREA F
    Focus on blood pressure: sex-specific association with atrial fibrillation, role of gliflozins in hypertension, and new therapeutic targets in hypertension and orthostatic hypotension.
    Eur Heart J. 2025;46:1277-1280.
    PubMed    
    
    
    
94. YUAN Y, Martsch P, Chen X, Martinez E, et al
    Atrial cardiomyocyte-restricted cleavage of gasdermin D promotes atrial arrhythmogenesis.
    Eur Heart J. 2025;46:1250-1262.
    PubMed     Abstract available
    
    
    
95. XIE D, Xiong K, Dong N, Wang G, et al
    An endogenous cholinergic system controls electrical conduction in the heart.
    Eur Heart J. 2025;46:1232-1246.
    PubMed     Abstract available
    
    
    
96. CREA F
    Learning from epidemiology: atrial fibrillation, peripheral artery disease, and twin pregnancy.
    Eur Heart J. 2025;46:1173-1177.
    PubMed    
    
    
    March 2025
97. SIONTIS KC, Friedman PA
    Predicting imminent ventricular arrhythmias from ambulatory ECG signals: far-reaching or too far to reach?
    Eur Heart J. 2025 Mar 30:ehaf008. doi: 10.1093.
    PubMed    
    
    
    
98. FIORINA L, Carbonati T, Narayanan K, Li J, et al
    Near-term prediction of sustained ventricular arrhythmias applying artificial intelligence to single-lead ambulatory electrocardiogram.
    Eur Heart J. 2025 Mar 30:ehaf073. doi: 10.1093.
    PubMed     Abstract available
    
    
    
99. GALLI M, Patrono C
    Weekly Journal Scan: Uncoupling thrombosis from hemostasis in atrial fibrillation? An AZALEA surfing over troubled water.
    Eur Heart J. 2025 Mar 25:ehaf145. doi: 10.1093.
    PubMed    
    
    
    
100. MAHMOUD B, Cox MGPJ, de Brouwer R, van der Heide MYC, et al
     Epicardial adipose tissue and malignant ventricular arrhythmias in phospholamban p.(Arg14del) variant carriers.
     Eur Heart J. 2025 Mar 11:ehaf118. doi: 10.1093.
     PubMed    
     
     
     
101. CREA F
     Non-traditional risk factors and artificial intelligence in the management of atrial fibrillation.
     Eur Heart J. 2025;46:771-774.
     PubMed    
     
     
     February 2025
102. BRUNO RM, Petiot EV
     Sex-specific pathways from vascular ageing to cardiac damage: unfavourable pulse pressure trajectories induce atrial fibrillation in women.
     Eur Heart J. 2025 Feb 24:ehaf039. doi: 10.1093.
     PubMed    
     
     
     
103. GUO J, Zhang Z, Meng X, Jing J, et al
     Atrial fibrillation catheter ablation, brain glymphatic function, and cognitive performance.
     Eur Heart J. 2025 Feb 21:ehaf036. doi: 10.1093.
     PubMed     Abstract available
     
     
     
104. BUNCH TJ
     Taking out the trash: the role of glymphatic function in cognitive function in patients with atrial fibrillation.
     Eur Heart J. 2025 Feb 21:ehaf040. doi: 10.1093.
     PubMed    
     
     
     
105. LEMOINE M, Rottner L, Kirchhof P
     Asymptomatic atrial fibrillation: the tasks ahead.
     Eur Heart J. 2025 Feb 3:ehae835. doi: 10.1093.
     PubMed    
     
     
     January 2025
106. KOTECHA D, Rienstra M, Van Gelder IC
     The '10 commandments' for the 2024 European Society of Cardiology guidelines on atrial fibrillation.
     Eur Heart J. 2025 Jan 29:ehae847. doi: 10.1093.
     PubMed    
     
     
     
107. VERGALLO R, Pedicino D
     Weekly Journal Scan: Is left atrial appendage closure a safe and effective OPTION after ablation for atrial fibrillation?
     Eur Heart J. 2025 Jan 28:ehae922. doi: 10.1093.
     PubMed    
     
     
     
108. GASPERETTI A, Carrick RT, Protonotarios A, Murray B, et al
     Clinical features and outcomes in carriers of pathogenic desmoplakin variants.
     Eur Heart J. 2025;46:362-376.
     PubMed     Abstract available
     
     
     
109. TZEIS S, Sepehri Shamloo A
     The decalogue of the 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society consensus document on catheter and surgical ablation of atrial fibrillation.
     Eur Heart J. 2025 Jan 17:ehae375. doi: 10.1093.
     PubMed    
     
     
     
110. SHARASHOVA E, Gerdts E, Ball J, Schnabel RB, et al
     Long-term pulse pressure trajectories and risk of incident atrial fibrillation: the Tromso Study.
     Eur Heart J. 2025 Jan 17:ehaf005. doi: 10.1093.
     PubMed     Abstract available
     
     
     
111. CREA F
     Focus on trials and prevention: suspected angina, atrial fibrillation, COVID, wine consumption, and physical activity.
     Eur Heart J. 2025;46:105-109.
     PubMed    
     
     
     
112. KALMAN JM, Kistler PM, Hindricks G, Sanders P, et al
     Atrial fibrillation ablation timing: where is the sweet spot?
     Eur Heart J. 2025 Jan 3:ehae892. doi: 10.1093.
     PubMed     Abstract available
     
     
     December 2024
113. ZHAO ZG, Chen F, Feng Y
     Left ventriculo-atrial fistula following catheter ablation for Wolff-Parkinson-White syndrome.
     Eur Heart J. 2024 Dec 24:ehae901. doi: 10.1093.
     PubMed    
     
     
     
114. LU Y, Sun Y, Cai L, Yu B, et al
     Non-traditional risk factors for atrial fibrillation: epidemiology, mechanisms, and strategies.
     Eur Heart J. 2024 Dec 24:ehae887. doi: 10.1093.
     PubMed     Abstract available
     
     
     
115. BORIANI G, Mei DA, Lip GYH
     Artificial intelligence in patients with atrial fibrillation to manage clinical complexity and comorbidities: the ARISTOTELES project.
     Eur Heart J. 2024 Dec 11:ehae792. doi: 10.1093.
     PubMed    
     
     
     
116. RIBEIRO AH, Ribeiro ALP
     AI-ECG and prediction of new atrial fibrillation: when the heart tells the age.
     Eur Heart J. 2024 Dec 9:ehae809. doi: 10.1093.
     PubMed    
     
     
     
117. VAN LOON T, Rijks J, van Koll J, Wolffs J, et al
     Accelerated atrial pacing reduces left-heart filling pressure: a combined clinical-computational study.
     Eur Heart J. 2024;45:4953-4964.
     PubMed     Abstract available
     
     
     
118. BRUNNER S, Krewitz C, Winter R, von Falkenhausen AS, et al
     Acute alcohol consumption and arrhythmias in young adults: the MunichBREW II study.
     Eur Heart J. 2024;45:4938-4949.
     PubMed     Abstract available
     
     
     
119. CREA F
     Focus on atrial fibrillation: role of atrioventricular node ablation, prediction by deep learning, and anticoagulation in device-detected arrhythmia.
     Eur Heart J. 2024;45:4873-4877.
     PubMed    
     
     
     
120. LIUZZO G, Patrono C
     Weekly Journal Scan: An EPIC comparison of edoxaban vs. dual antithrombotic therapy in atrial fibrillation and stable coronary artery disease.
     Eur Heart J. 2024 Dec 4:ehae787. doi: 10.1093.
     PubMed    
     
     
     
121. SUN Y, Wang Z, Qian Y
     What's the relationship between secondary mitral regurgitation and secondary tricuspid regurgitation in atrial fibrillation patients and how to treat them?
     Eur Heart J. 2024 Dec 4:ehae815. doi: 10.1093.
     PubMed    
     
     
     November 2024
122. CHO S, Eom S, Kim D, Kim TH, et al
     Artificial intelligence-derived electrocardiographic aging and risk of atrial fibrillation: a multi-national study.
     Eur Heart J. 2024 Nov 29:ehae790. doi: 10.1093.
     PubMed     Abstract available
     
     
     
123. KONERU JN, Ellenbogen KA
     Ablation of persistent atrial fibrillation: lessons learnt from the CAPLA trial.
     Eur Heart J. 2024 Nov 27:ehae832. doi: 10.1093.
     PubMed    
     
     
     
124. MEYER M
     Accelerated pacing as a treatment for heart failure with preserved ejection fraction and atrial fibrillation?
     Eur Heart J. 2024 Nov 26:ehae766. doi: 10.1093.
     PubMed    
     
     
     
125. ORTEGA-MARTORELL S, Olier I, Lip GYH
     A European network to develop virtual twin technology for personalized stroke management in atrial fibrillation: the TARGET consortium.
     Eur Heart J. 2024 Nov 20:ehae673. doi: 10.1093.
     PubMed    
     
     
     
126. LINZ D, Chaldoupi SM
     Stroke risk in device-detected atrial fibrillation is modulated by the continuum of vascular disease burden.
     Eur Heart J. 2024 Nov 19:ehae797. doi: 10.1093.
     PubMed    
     
     
     
127. VERKAIK BJ, Walker RG, Taylor TG, Ekkel MM, et al
     Defibrillation and refractory ventricular fibrillation.
     Eur Heart J. 2024 Nov 18:ehae767. doi: 10.1093.
     PubMed    
     
     
     
128. NEEFS J, Krul SPJ, de Groot JR
     A CHA2DS2-VASc score of 1 is not the same for every patient with atrial fibrillation.
     Eur Heart J. 2024 Nov 11:ehae511. doi: 10.1093.
     PubMed    
     
     
     
129. BORIANI G, Mei DA, Imberti JF
     Personalized clinical management of patients with atrial fibrillation: is a biomarker-based strategy for prediction of sinus rhythm persistence ready for prime time?
     Eur Heart J. 2024 Nov 9:ehae720. doi: 10.1093.
     PubMed    
     
     
     
130. KANY S, Ellinor PT, Khurshid S
     Another piece in the puzzle of atrial fibrillation risk: clinical, genetic, and electrocardiogram-based artificial intelligence.
     Eur Heart J. 2024 Nov 4:ehae691. doi: 10.1093.
     PubMed    
     
     
     October 2024
131. LIUZZO G, Patrono C
     Weekly Journal Scan: the rise and OCEANIC fall of asundexian in atrial fibrillation.
     Eur Heart J. 2024 Oct 25:ehae728. doi: 10.1093.
     PubMed    
     
     
     
132. TARANTINO A, Ciconte G, Melgari D, Frosio A, et al
     NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implications.
     Eur Heart J. 2024;45:4336-4348.
     PubMed     Abstract available
     
     
     
133. KARAKASIS P, Pamporis K, Siontis KC, Theofilis P, et al
     Major clinical outcomes in symptomatic vs. asymptomatic atrial fibrillation: a meta-analysis.
     Eur Heart J. 2024 Oct 21:ehae694. doi: 10.1093.
     PubMed     Abstract available
     
     
     
134. CREA F
     Innovative approaches to the management of recurrent atrial fibrillation, aortic dilation, and Brugada syndrome.
     Eur Heart J. 2024;45:4245-4248.
     PubMed    
     
     
     
135. CHARTON J, Bouteiller X, Gandjbakhch E, Waintraub X, et al
     Overdrive pacing for ventricular fibrillation storm after myocardial infarction.
     Eur Heart J. 2024 Oct 18:ehae698. doi: 10.1093.
     PubMed    
     
     
     
136. ORAII A, Healey JS, McIntyre WF
     Mineralocorticoid receptor antagonists for atrial fibrillation prevention: effective solution or empty promise?
     Eur Heart J. 2024 Oct 17:ehae687. doi: 10.1093.
     PubMed    
     
     
     
137. SAMPAIO RODRIGUES T, Sanders P, Lim HS
     Utility of mineralocorticoid receptor antagonists in reducing burden of atrial fibrillation.
     Eur Heart J. 2024 Oct 17:ehae686. doi: 10.1093.
     PubMed    
     
     
     
138. 
     Correction to: An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis.
     Eur Heart J. 2024 Oct 15:ehae394. doi: 10.1093.
     PubMed    
     
     
     
139. JOZA J, Burri H, Andrade JG, Linz D, et al
     Atrioventricular node ablation for atrial fibrillation in the era of conduction system pacing.
     Eur Heart J. 2024 Oct 14:ehae656. doi: 10.1093.
     PubMed     Abstract available
     
     
     
140. GALIUTO L, Patrono C
     Weekly Journal Scan: Risk factors for recurrent ischaemic stroke in patients with atrial fibrillation on oral anticoagulation.
     Eur Heart J. 2024 Oct 3:ehae630. doi: 10.1093.
     PubMed    
     
     
     
141. 
     Correction to: Prognostic value of ventricular arrhythmia in early post-infarction left ventricular dysfunction: the French nationwide WICD-MI study.
     Eur Heart J. 2024 Oct 1:ehae693. doi: 10.1093.
     PubMed    
     
     
     September 2024
142. XU Y, Li H, Santosa A, Wettermark B, et al
     Cardiovascular events following coronavirus disease 2019 vaccination in adults: a nationwide Swedish study.
     Eur Heart J. 2024 Sep 30:ehae639. doi: 10.1093.
     PubMed     Abstract available
     
     
     
143. CREA F
     New Guidelines and a focus on ischaemic heart disease, atrial fibrillation, innovative treatments of channelopathies.
     Eur Heart J. 2024;45:3299-3302.
     PubMed    
     
     
     
144. NATALE A, Mohanty S, Sanders P, Anter E, et al
     Catheter ablation for atrial fibrillation: indications and future perspective.
     Eur Heart J. 2024 Sep 26:ehae618. doi: 10.1093.
     PubMed     Abstract available
     
     
     
145. ECHIVARD M, Sellal JM, Ziliox C, Marijon E, et al
     Prognostic value of ventricular arrhythmia in early post-infarction left ventricular dysfunction: the French nationwide WICD-MI study.
     Eur Heart J. 2024 Sep 20:ehae575. doi: 10.1093.
     PubMed     Abstract available
     
     
     
146. GAWALKO M, Middeldorp ME, Saljic A, Penders J, et al
     Diet and risk of atrial fibrillation: a systematic review.
     Eur Heart J. 2024 Sep 17:ehae551. doi: 10.1093.
     PubMed     Abstract available
     
     
     
147. SCHNABEL RB, Benezet-Mazuecos J, Becher N, McIntyre WF, et al
     Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials.
     Eur Heart J. 2024 Sep 2:ehae596. doi: 10.1093.
     PubMed     Abstract available
     
     
     
148. HAVERS-BORGERSEN E, Hartwell D, Ekelund C, Butt JH, et al
     Endometriosis and Long-Term Cardiovascular Risk: A Nationwide Danish study.
     Eur Heart J. 2024 Sep 2:ehae563. doi: 10.1093.
     PubMed     Abstract available
     
     
     
149. LIP GYH, Teppo K, Nielsen PB
     CHA2DS2-VASc or a non-sex score (CHA2DS2-VA) for stroke risk prediction in atrial fibrillation: contemporary insights and clinical implications.
     Eur Heart J. 2024 Sep 1:ehae540. doi: 10.1093.
     PubMed    
     
     
     
150. CHAMPSI A, Mobley AR, Subramanian A, Nirantharakumar K, et al
     Gender and contemporary risk of adverse events in atrial fibrillation.
     Eur Heart J. 2024 Sep 1:ehae539. doi: 10.1093.
     PubMed     Abstract available
     
     
     
151. JABBOUR G, Nolin-Lapalme A, Tastet O, Corbin D, et al
     Prediction of incident atrial fibrillation using deep learning, clinical models and polygenic scores.
     Eur Heart J. 2024 Sep 1:ehae595. doi: 10.1093.
     PubMed     Abstract available
     
     
     August 2024
152. WILLIAM J, Chieng D, Curtin AG, Sugumar H, et al
     Radiofrequency catheter ablation of persistent atrial fibrillation by pulmonary vein isolation with or without left atrial posterior wall isolation: long-term outcomes of the CAPLA trial.
     Eur Heart J. 2024 Aug 31:ehae580. doi: 10.1093.
     PubMed     Abstract available
     
     
     
153. FABRITZ L, Al-Taie C, Borof K, Breithardt G, et al
     Biomarker-based prediction of sinus rhythm in atrial fibrillation patients: the EAST-AFNET 4 biomolecule study.
     Eur Heart J. 2024 Aug 31:ehae611. doi: 10.1093.
     PubMed     Abstract available
     
     
     
154. VAN GELDER IC, Rienstra M, Bunting KV, Casado-Arroyo R, et al
     2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).
     Eur Heart J. 2024 Aug 30:ehae176. doi: 10.1093.
     PubMed    
     
     
     
155. HUANG H, Liu Y, Shuai W, Jiang C, et al
     Atrial tachyarrhythmia prevention by Shensong Yangxin after catheter ablation for persistent atrial fibrillation: the SS-AFRF trial.
     Eur Heart J. 2024 Aug 23:ehae532. doi: 10.1093.
     PubMed     Abstract available
     
     
     
156. BOVEDA S, Sarkozy A, Duncker D, Merino JL, et al
     European Heart Rhythm Association congress: a constantly reinvented meeting.
     Eur Heart J. 2024;45:2905-2907.
     PubMed    
     
     
     
157. CARRICK RT, Gasperetti A, Protonotarios A, Murray B, et al
     A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers.
     Eur Heart J. 2024;45:2968-2979.
     PubMed     Abstract available
     
     
     
158. CREA F
     Expanding knowledge in atrial fibrillation, blood pressure treatment, and management of coronary and peripheral artery disease.
     Eur Heart J. 2024;45:2795-2799.
     PubMed    
     
     
     
159. CONTE G, Bergonti M
     Implantable loop recorders in Brugada syndrome: symptoms and arrhythmia characterization.
     Eur Heart J. 2024;45:2895.
     PubMed    
     
     
     
160. DENDRAMIS G
     Implantable loop recorders in patients with Brugada syndrome: the importance of a correct patient stratification.
     Eur Heart J. 2024;45:2894.
     PubMed    
     
     
     
161. BAINS S, Giammarino L, Nimani S, Alerni N, et al
     KCNQ1 suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndrome.
     Eur Heart J. 2024 Aug 8:ehae476. doi: 10.1093.
     PubMed     Abstract available
     
     
     
162. CREA F
     Spotlight on hot topics: subclinical atrial fibrillation, risk stratification of channelopathies, and cardioprotection.
     Eur Heart J. 2024;45:2579-2583.
     PubMed    
     
     
     
163. TSUJI T, Hasegawa K, Tada H
     Left atrial diverticulum as a rare but possible origin of a sustained atrial tachycardia: a case report.
     Eur Heart J. 2024;45:2679.
     PubMed    
     
     
     July 2024
164. KANY S, Jurgens SJ, Ramo JT, Christophersen IE, et al
     Genetic testing in early-onset atrial fibrillation.
     Eur Heart J. 2024 Jul 19:ehae298. doi: 10.1093.
     PubMed     Abstract available
     
     
     
165. LANDMESSER U, Skurk C, Tzikas A, Falk V, et al
     Left atrial appendage closure for stroke prevention in atrial fibrillation: current status and perspectives.
     Eur Heart J. 2024 Jul 19:ehae398. doi: 10.1093.
     PubMed     Abstract available
     
     
     
166. ANDREOTTI F, De Caterina R
     Anticoagulation for transient atrial fibrillation post-coronary bypass: high quality evidence needed.
     Eur Heart J. 2024 Jul 16:ehae402. doi: 10.1093.
     PubMed    
     
     
     
167. KAJIHARA Y
     Edoxaban-induced oesophagitis.
     Eur Heart J. 2024;45:2460.
     PubMed    
     
     
     
168. CHOI YJ, Lim J, Bea S, Lee J, et al
     Thromboembolism after coronavirus disease 2019 vaccination in atrial fibrillation/flutter: a self-controlled case series study.
     Eur Heart J. 2024 Jul 12:ehae335. doi: 10.1093.
     PubMed     Abstract available
     
     
     
169. CONNORS JM
     Thrombotic risks associated with COVID-19 vaccination in atrial fibrillation or atrial flutter: no reason for alarm.
     Eur Heart J. 2024 Jul 12:ehae336. doi: 10.1093.
     PubMed    
     
     
     
170. WILDE AAM, van der Werf C
     Risk scores in congenital long QT syndrome: friend or foe?
     Eur Heart J. 2024 Jul 10:ehae408. doi: 10.1093.
     PubMed    
     
     
     
171. CREA F
     A new classification of iron-deficient heart failure, sex-related differences in the management of atrial fibrillation and mitral regurgitation, and an update on the genetics of Brugada syndrome.
     Eur Heart J. 2024;45:2267-2270.
     PubMed    
     
     
     
172. BEHR ER
     Brugada syndrome: can polygenic risk scores help the clinician?
     Eur Heart J. 2024;45:2333-2335.
     PubMed    
     
     
     
173. SCACCIAVILLANI R
     Percutaneous stellate ganglion block for electrical storm treatment: the new rising STAR?
     Eur Heart J. 2024;45:2263.
     PubMed    
     
     
     
174. SAVASTANO S, Baldi E, Rordorf R
     Percutaneous stellate ganglion block and catheter ablation: not enemies but allies in fighting electrical storm.
     Eur Heart J. 2024;45:2264.
     PubMed    
     
     
     
175. ISHIKAWA T, Masuda T, Hachiya T, Dina C, et al
     Brugada syndrome in Japan and Europe: a genome-wide association study reveals shared genetic architecture and new risk loci.
     Eur Heart J. 2024;45:2320-2332.
     PubMed     Abstract available
     
     
     
176. AIRAKSINEN KEJ, De Sensi F
     Ten years of direct oral anticoagulants: lessons learned and challenges ahead.
     Eur Heart J. 2024;45:2178-2180.
     PubMed    
     
     
     
177. MURARU D, Badano LP
     Impact of new-onset atrial fibrillation on the incidence of tricuspid regurgitation: a call to attention.
     Eur Heart J. 2024 Jul 8:ehae382. doi: 10.1093.
     PubMed    
     
     
     
178. LV L
     What influences the bleeding risk of long-term anticoagulation after catheter ablation in patients with atrial fibrillation at high risk of thromboembolism?
     Eur Heart J. 2024 Jul 2:ehae388. doi: 10.1093.
     PubMed    
     
     
     
179. KANAOKA K, Iwanaga Y
     Oral anticoagulant use after catheter ablation for atrial fibrillation based on thrombo-embolic risk: future studies will be needed for bleeding high-risk group.
     Eur Heart J. 2024 Jul 2:ehae389. doi: 10.1093.
     PubMed    
     
     
     
180. BECHER N, Metzner A, Toennis T, Kirchhof P, et al
     Atrial fibrillation burden: a new outcome predictor and therapeutic target.
     Eur Heart J. 2024 Jul 2:ehae373. doi: 10.1093.
     PubMed     Abstract available
     
     
     
181. NASER JA, Castrichini M, Ibrahim HH, Scott CG, et al
     Secondary tricuspid regurgitation: incidence, types, and outcomes in atrial fibrillation vs. sinus rhythm.
     Eur Heart J. 2024 Jul 2:ehae346. doi: 10.1093.
     PubMed     Abstract available
     
     
     June 2024
182. CREA F
     A focus on three hot topics: atrial fibrillation, obesity, and climate change.
     Eur Heart J. 2024;45:2105-2108.
     PubMed    
     
     
     
183. SANDERS P, Svennberg E, Diederichsen SZ, Crijns HJGM, et al
     Great debate: device-detected subclinical atrial fibrillation should be treated like clinical atrial fibrillation.
     Eur Heart J. 2024 Jun 27:ehae365. doi: 10.1093.
     PubMed    
     
     
     
184. SAMUEL M, Rienstra M, Van Gelder IC
     Ablation of persistent atrial fibrillation: never say never again.
     Eur Heart J. 2024 Jun 18:ehae374. doi: 10.1093.
     PubMed    
     
     
     
185. KHAIRY P
     A non-invasive gateway to identifying potential substrates for macro-reentrant ventricular tachycardia in tetralogy of Fallot.
     Eur Heart J. 2024;45:2095-2097.
     PubMed    
     
     
     
186. KIMURA Y, Wallet J, Bouyer B, Jongbloed MRM, et al
     Three-dimensional cardiac magnetic resonance allows the identification of slow-conducting anatomical isthmuses in tetralogy of Fallot.
     Eur Heart J. 2024;45:2079-2094.
     PubMed     Abstract available
     
     
     
187. STEINBERG BA
     Atrial fibrillation and long-term cardiovascular outcomes: bringing the whole picture into focus.
     Eur Heart J. 2024 Jun 7:ehae347. doi: 10.1093.
     PubMed    
     
     
     
188. FARMAKIS D, Filippatos G
     Cancer begets atrial fibrillation ... and vice versa?
     Eur Heart J. 2024 Jun 7:ehae301. doi: 10.1093.
     PubMed    
     
     
     
189. JOHNSON LS, Jiang Y, Luu J, Van Gelder IC, et al
     Emergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry.
     Eur Heart J. 2024 Jun 4:ehae319. doi: 10.1093.
     PubMed    
     
     
     May 2024
190. WANG J, Chen X, Zhao S
     Detect and define ventricular arrhythmia substrates in hypertrophic cardiomyopathy.
     Eur Heart J. 2024 May 31:ehae312. doi: 10.1093.
     PubMed    
     
     
     
191. VAN DE KAR MRD, van Brakel TJ, Van't Veer M, van Steenbergen GJ, et al
     Anticoagulation for post-operative atrial fibrillation after isolated coronary artery bypass grafting: a meta-analysis.
     Eur Heart J. 2024 May 29:ehae267. doi: 10.1093.
     PubMed     Abstract available
     
     
     
192. NAGAE H, Kayawake H, Taniguchi T
     Chest tube-related complete atrioventricular block.
     Eur Heart J. 2024 May 28:ehae315. doi: 10.1093.
     PubMed    
     
     
     
193. BRIEGER D, Freedman B
     Taking the sex out of atrial fibrillation.
     Eur Heart J. 2024 May 24:ehae256. doi: 10.1093.
     PubMed    
     
     
     
194. CHAUHAN A, Banerjee A
     Atrial fibrillation and flutter: reiterating the need to 'Go hard, Go early'.
     Eur Heart J. 2024 May 23:ehae029. doi: 10.1093.
     PubMed    
     
     
     
195. CRIJNS HJGM, Lambiase PD, Sanders P
     The year in cardiovascular medicine 2023: the top 10 papers in arrhythmias.
     Eur Heart J. 2024;45:1730-1732.
     PubMed    
     
     
     
196. CROWLEY R, Chieng D, Sugumar H, Ling LH, et al
     Catheter ablation for persistent atrial fibrillation: patterns of recurrence and impact on quality of life and health care utilisation.
     Eur Heart J. 2024 May 17:ehae291. doi: 10.1093.
     PubMed     Abstract available
     
     
     
197. DUSI V, Dagradi F, Spazzolini C, Crotti L, et al
     Long QT syndrome: importance of reassessing arrhythmic risk after treatment initiation.
     Eur Heart J. 2024 May 16:ehae289. doi: 10.1093.
     PubMed     Abstract available
     
     
     
198. SABBAG A, Aabel EW, Castrini AI, Siontis KC, et al
     Mitral valve prolapse: arrhythmic risk during pregnancy and postpartum.
     Eur Heart J. 2024 May 14:ehae224. doi: 10.1093.
     PubMed     Abstract available
     
     
     
199. ZEPPENFELD K, de Riva M
     Arrhythmic risk in young women with mitral valve prolapse: keep your eyes open but don't jump at every shadow.
     Eur Heart J. 2024 May 14:ehae246. doi: 10.1093.
     PubMed    
     
     
     
200. VANDERSICKEL N, Hendrickx S, Van den Abeele R, Verstraeten B, et al
     Impact of topology on the number of loops during macro-re-entrant atrial tachycardia.
     Eur Heart J. 2024;45:1586-1588.
     PubMed    
     
     
     
201. TAN Y, Tao Y, Wang Z
     Isolated right-sided pericardial effusion following hybrid ablation for long-standing atrial fibrillation.
     Eur Heart J. 2024 May 4:ehae210. doi: 10.1093.
     PubMed    
     
     
     April 2024
202. NGO LTH, Peng Y, Denman R, Yang I, et al
     Long-term outcomes after hospitalization for atrial fibrillation or flutter.
     Eur Heart J. 2024 Apr 28:ehae204. doi: 10.1093.
     PubMed     Abstract available
     
     
     
203. LI YP, Chen JY
     Rapid onset of takotsubo cardiomyopathy induced by left bundle branch area pacing.
     Eur Heart J. 2024;45:1487.
     PubMed    
     
     
     
204. 
     Correction to: XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation.
     Eur Heart J. 2024 Apr 17:ehae227. doi: 10.1093.
     PubMed    
     
     
     
205. CHEN Q, van Rein N, van der Hulle T, Heemelaar JC, et al
     Coexisting atrial fibrillation and cancer: time trends and associations with mortality in a nationwide Dutch study.
     Eur Heart J. 2024 Apr 15:ehae222. doi: 10.1093.
     PubMed     Abstract available
     
     
     
206. TEPPO K, Airaksinen KEJ, Jaakkola J, Halminen O, et al
     Ischaemic stroke in women with atrial fibrillation: temporal trends and clinical implications.
     Eur Heart J. 2024 Apr 12:ehae198. doi: 10.1093.
     PubMed     Abstract available
     
     
     
207. PALUDAN-MULLER C, Vad OB, Stampe NK, Diederichsen SZ, et al
     Atrial fibrillation: age at diagnosis, incident cardiovascular events, and mortality.
     Eur Heart J. 2024 Apr 9:ehae216. doi: 10.1093.
     PubMed     Abstract available
     
     
     
208. LIP GYH, Nikorowitsch J, Sehner S, Becher N, et al
     Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial.
     Eur Heart J. 2024 Apr 9:ehae225. doi: 10.1093.
     PubMed    
     
     
     
209. CREA F
     The complex interaction between cancer, ischaemic heart disease, and heart failure, and a focus on arrhythmias including risk stratification in Brugada syndrome and leadless pacing.
     Eur Heart J. 2024;45:1183-1187.
     PubMed    
     
     
     
210. GAITA F, Cerrato N, Giustetto C
     Can an implantable loop recorder improve risk stratification and appropriate management in Brugada syndrome?
     Eur Heart J. 2024;45:1266-1268.
     PubMed    
     
     
     
211. BERGONTI M, Sacher F, Arbelo E, Crotti L, et al
     Implantable loop recorders in patients with Brugada syndrome: the BruLoop study.
     Eur Heart J. 2024;45:1255-1265.
     PubMed     Abstract available
     
     
     
212. EL-CHAMI MF, Garweg C, Clementy N, Al-Samadi F, et al
     Leadless pacemakers at 5-year follow-up: the Micra transcatheter pacing system post-approval registry.
     Eur Heart J. 2024;45:1241-1251.
     PubMed     Abstract available
     
     
     
213. LIUZZO G, Pedicino D
     Weekly journal scan: the KCa2 potassium channel as a promising target for the pharmacologic cardioversion of atrial fibrillation.
     Eur Heart J. 2024 Apr 1:ehae138. doi: 10.1093.
     PubMed    
     
     
     March 2024
214. CREA F
     Challenges in arrhythmias: anticoagulation in asymptomatic atrial fibrillation, stellate ganglion block in electrical storm, and ECG for prediction of sudden death.
     Eur Heart J. 2024;45:739-743.
     PubMed    
     
     
     
215. ZURIAGA MA, Pascual-Figal D, Fuster JJ
     Clonal haematopoiesis and cardiac arrythmias: rhythm-altering mutations.
     Eur Heart J. 2024;45:806-808.
     PubMed    
     
     
     
216. SAVASTANO S, Baldi E, Compagnoni S, Rordorf R, et al
     Electrical storm treatment by percutaneous stellate ganglion block: the STAR study.
     Eur Heart J. 2024;45:823-833.
     PubMed     Abstract available
     
     
     
217. FIALHO GL
     Epilepsy and the heart: can 'brain arrhythmia' lead to cardiac arrhythmias? Back to the basics.
     Eur Heart J. 2024;45:853-854.
     PubMed    
     
     
     
218. PHAM HN, Holmstrom L, Chugh H, Uy-Evanado A, et al
     Dynamic electrocardiogram changes are a novel risk marker for sudden cardiac death.
     Eur Heart J. 2024;45:809-819.
     PubMed     Abstract available
     
     
     
219. SCHUERMANS A, Vlasschaert C, Nauffal V, Cho SMJ, et al
     Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias.
     Eur Heart J. 2024;45:791-805.
     PubMed     Abstract available
     
     
     
220. SUN Y, Zhou Y, Yu B, Zhang K, et al
     Frailty, genetic predisposition, and incident atrial fibrillation.
     Eur Heart J. 2024 Mar 5:ehae130. doi: 10.1093.
     PubMed    
     
     
     
221. SUDO K, Nakamura K, Sato A
     Usefulness of endomyocardial biopsy using three-dimensional delivery system for the diagnosis of cardiac amyloidosis with complete atrioventricular block after transcatheter aortic valve implantation.
     Eur Heart J. 2024 Mar 5:ehae137. doi: 10.1093.
     PubMed    
     
     
     
222. MURARU D, Badano LP, Hahn RT, Lang RM, et al
     Atrial secondary tricuspid regurgitation: pathophysiology, definition, diagnosis, and treatment.
     Eur Heart J. 2024 Mar 5:ehae088. doi: 10.1093.
     PubMed     Abstract available
     
     
     February 2024
223. SVENNBERG E, Diederichsen SZ
     Anticoagulation in device-detected atrial fibrillation: a long journey to find the sweet spot.
     Eur Heart J. 2024 Feb 21:ehae044. doi: 10.1093.
     PubMed    
     
     
     
224. CREA F
     Anticoagulation in atrial fibrillation and implantable cardioverter defibrillator implantation in arrhythmogenic right ventricular cardiomyopathy: need for improving patient selection.
     Eur Heart J. 2024;45:491-494.
     PubMed    
     
     
     
225. MALIK V, Shivkumar K
     Stellate ganglion blockade for the management of ventricular arrhythmia storm.
     Eur Heart J. 2024 Feb 15:ehae083. doi: 10.1093.
     PubMed    
     
     
     
226. HOLT A, Nouhravesh N, Strange JE, Kinnberg Nielsen S, et al
     Cannabis for chronic pain: cardiovascular safety in a nationwide Danish study.
     Eur Heart J. 2024;45:475-484.
     PubMed     Abstract available
     
     
     
227. ZURKAN D, Pitt B, Edelmann F
     Mineralocorticoid receptor antagonists for the prevention of atrial fibrillation in patients with and without heart failure: one more beneficial effect?
     Eur Heart J. 2024 Feb 6:ehae040. doi: 10.1093.
     PubMed    
     
     
     
228. LIUZZO G, Patrono C
     Edoxaban for atrial high-rate episodes: more harm than good?
     Eur Heart J. 2024;45:330-331.
     PubMed    
     
     
     January 2024
229. ELLIOTT PM
     Transatlantic differences in the use of implantable cardioverter defibrillators in arrhythmogenic right ventricular cardiomyopathy.
     Eur Heart J. 2024 Jan 30:ehae022. doi: 10.1093.
     PubMed    
     
     
     
230. YOUNES H, Rao S, Marrouche N
     Deciphering connections: how is cryoablation interlinking with disease progression in atrial fibrillation ablation?
     Eur Heart J. 2024 Jan 24:ehad872. doi: 10.1093.
     PubMed    
     
     
     
231. BRIENESSE S, Passman R, Freedman B
     Interruption of oral anticoagulants after atrial fibrillation catheter ablation: the importance of risk stratification.
     Eur Heart J. 2024 Jan 23:ehad874. doi: 10.1093.
     PubMed    
     
     
     
232. DEHARO P, Obadia JF, Guerin P, Cuisset T, et al
     Mitral transcatheter edge to edge repair versus isolated mitral surgery for severe mitral regurgitation: A French nationwide study.
     Eur Heart J. 2024 Jan 19:ehae046. doi: 10.1093.
     PubMed     Abstract available
     
     
     
233. VERGALLO R, Galiuto L
     Targeting inflammation with colchicine does not prevent atrial fibrillation after major non-cardiac thoracic surgery.
     Eur Heart J. 2024 Jan 18:ehae006. doi: 10.1093.
     PubMed    
     
     
     
234. AHN HJ, An HY, Ryu G, Lim J, et al
     Clonal haematopoiesis of indeterminate potential and atrial fibrillation: an east Asian cohort study.
     Eur Heart J. 2024 Jan 17:ehad869. doi: 10.1093.
     PubMed     Abstract available
     
     
     
235. SAMARAS A, Papazoglou AS, Balomenakis C, Bekiaridou A, et al
     Residual leaks following percutaneous left atrial appendage occlusion and outcomes: a meta-analysis.
     Eur Heart J. 2024;45:214-229.
     PubMed     Abstract available
     
     
     
236. ORAII A, Healey JS, Kowalik K, Pandey AK, et al
     Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis of clinical trials.
     Eur Heart J. 2024 Jan 9:ehad811. doi: 10.1093.
     PubMed     Abstract available
     
     
     
237. CARRICK RT, De Marco C, Gasperetti A, Bosman LP, et al
     Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe.
     Eur Heart J. 2024 Jan 9:ehad799. doi: 10.1093.
     PubMed     Abstract available
     
     
     
238. LIUZZO G, Patrono C
     Balancing the benefits and risks of anticoagulation in patients with subclinical atrial fibrillation.
     Eur Heart J. 2024 Jan 8:ehad859. doi: 10.1093.
     PubMed    
     
     
     
239. CREA F
     The key role of thrombosis: focus on acute coronary syndrome, venous thrombo-embolism, and atrial fibrillation.
     Eur Heart J. 2024;45:1-4.
     PubMed    
     
     
     
240. PIESZKO K, Hiczkiewicz J, Lojewska K, Uzieblo-Zyczkowska B, et al
     Artificial intelligence in detecting left atrial appendage thrombus by transthoracic echocardiography and clinical features: the Left Atrial Thrombus on Transoesophageal Echocardiography (LATTEE) registry.
     Eur Heart J. 2024;45:32-41.
     PubMed     Abstract available
     
     
     December 2023
241. PROVIDENCIA R, Kukendra-Rajah K, Barra S
     Amiodarone for atrial fibrillation: a dead man walking?
     Eur Heart J. 2023 Dec 29:ehad825. doi: 10.1093.
     PubMed    
     
     
     
242. KRAMARENKO D, Walsh R
     Emery-Dreifuss muscular dystrophy: a closer look at cardiac complications.
     Eur Heart J. 2023;44:5074-5076.
     PubMed    
     
     
     
243. KANAOKA K, Nishida T, Iwanaga Y, Nakai M, et al
     Oral anticoagulation after atrial fibrillation catheter ablation: benefits and risks.
     Eur Heart J. 2023 Dec 20:ehad798. doi: 10.1093.
     PubMed     Abstract available
     
     
     
244. HATALA R, Hlivak P
     Atrial fibrillation in chronic coronary syndromes: a neglected challenge.
     Eur Heart J. 2023 Dec 17:ehad781. doi: 10.1093.
     PubMed    
     
     
     November 2023
245. SPOSATO LA, Lip GYH, Haeusler KG
     Atrial fibrillation first detected after stroke: is timing and detection intensity relevant for stroke risk?
     Eur Heart J. 2023 Nov 28:ehad744. doi: 10.1093.
     PubMed    
     
     
     
246. ANJUM M, Ariansen I, Hjellvik V, Selmer R, et al
     Stroke and bleeding risk in atrial fibrillation with CHA2DS2-VASC risk score of one: the Norwegian AFNOR study.
     Eur Heart J. 2023 Nov 23:ehad659. doi: 10.1093.
     PubMed     Abstract available
     
     
     
247. MARCHLINSKI FE, Oraii A, Muser D
     Anticoagulation for atrial fibrillation in patients with intermediate stroke risk: is the grey zone becoming less grey?
     Eur Heart J. 2023 Nov 23:ehad751. doi: 10.1093.
     PubMed    
     
     
     
248. BECHER N, Toennis T, Bertaglia E, Blomstrom-Lundqvist C, et al
     Anticoagulation with edoxaban in patients with long Atrial High-Rate Episodes >/=24 hours.
     Eur Heart J. 2023 Nov 12:ehad771. doi: 10.1093.
     PubMed     Abstract available
     
     
     
249. TSABAN G, Ostrovsky D, Alnsasra H, Burrack N, et al
     Amiodarone and pulmonary toxicity in atrial fibrillation: a nationwide Israeli study.
     Eur Heart J. 2023 Nov 6:ehad726. doi: 10.1093.
     PubMed     Abstract available
     
     
     
250. DEMIDOVA MM, Holmqvist F, Erlinge D, Platonov PG, et al
     Ventricular arrhythmias during ST-segment elevation myocardial infarction and arrhythmic complications during recurrent ischaemic events.
     Eur Heart J. 2023 Nov 3:ehad740. doi: 10.1093.
     PubMed    
     
     
     
251. INCIARDI RM, Solomon SD
     Beyond the rhythm: atrial fibrillation, diastolic dysfunction, and heart failure.
     Eur Heart J. 2023 Nov 3:ehad747. doi: 10.1093.
     PubMed    
     
     
     October 2023
252. ELLIOTT AD, Benjamin EJ, Middeldorp ME
     Prevention of atrial fibrillation: a call to action.
     Eur Heart J. 2023 Oct 31:ehad738. doi: 10.1093.
     PubMed    
     
     
     
253. TILZ RR, Heeger CH
     Be aware and hit hard and early: oesophageal lesions after atrial fibrillation ablation.
     Eur Heart J. 2023 Oct 26:ehad692. doi: 10.1093.
     PubMed    
     
     
     
254. SCANAVACCA M, Pisani C, Rivarola EWR
     Early identification of oesophageal lesions after atrial fibrillation ablation to prevent atrio-oesophageal fistula.
     Eur Heart J. 2023 Oct 26:ehad689. doi: 10.1093.
     PubMed    
     
     
     
255. CREA F
     Innovative trials in heart failure, dyslipidaemias, and sinus node dysfunction.
     Eur Heart J. 2023;44:4203-4207.
     PubMed    
     
     
     
256. PEDICINO D, Volpe M
     Atrial fibrillation ablation improves outcomes in patients with end-stage heart failure: is it all gold the glitter in the CASTLE?
     Eur Heart J. 2023 Oct 17:ehad675. doi: 10.1093.
     PubMed    
     
     
     
257. MARX N, Federici M, Schutt K, Muller-Wieland D, et al
     2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes.
     Eur Heart J. 2023;44:4043-4140.
     PubMed    
     
     
     
258. APOSTOLOS A, Aggeli C, Toutouzas K
     Nickel hypersensitivity as the cause of atrial fibrillation after patent foramen ovale closure: fact or myth?
     Eur Heart J. 2023 Oct 4:ehad643. doi: 10.1093.
     PubMed    
     
     
     
259. PAPIOL E, Pastor P, Pueo E
     Skin lesions, weight loss, and ventricular tachycardia: connecting the dots to diagnose multisystemic sarcoidosis.
     Eur Heart J. 2023;44:3705.
     PubMed    
     
     
     September 2023
260. LI E, Yan C, Yang X
     Long QT syndrome induced by cervical spondylosis.
     Eur Heart J. 2023 Sep 22:ehad608. doi: 10.1093.
     PubMed    
     
     
     
261. CREA F
     Challenges and opportunities in prognostication: focus on ischaemic heart disease and atrial fibrillation.
     Eur Heart J. 2023;44:3391-3394.
     PubMed    
     
     
     
262. TANAKA Y, Kuroki K, Kaga S
     Life-threatening left atrioesophageal fistula complicated with catheter ablation for atrial fibrillation in a patient with aortic stent graft.
     Eur Heart J. 2023 Sep 19:ehad609. doi: 10.1093.
     PubMed    
     
     
     
263. WANG N, Yu Y, Sun Y, Zhang H, et al
     Acquired risk factors and incident atrial fibrillation according to age and genetic predisposition.
     Eur Heart J. 2023 Sep 19:ehad615. doi: 10.1093.
     PubMed     Abstract available
     
     
     
264. CREA F
     Focus on atrial fibrillation in specific clinical settings and on calmodulinopathy.
     Eur Heart J. 2023;44:3299-3302.
     PubMed    
     
     
     
265. WANG J, Huang P, Yu Q, Lu J, et al
     Epilepsy and long-term risk of arrhythmias.
     Eur Heart J. 2023;44:3374-3382.
     PubMed     Abstract available
     
     
     
266. BARSHESHET A, Goldenberg I
     Advancing personalized medicine: the power of collaborative registries of patients with inherited cardiac arrhythmia syndromes.
     Eur Heart J. 2023;44:3371-3373.
     PubMed    
     
     
     
267. CROTTI L, Spazzolini C, Nyegaard M, Overgaard MT, et al
     Clinical presentation of calmodulin mutations: the International Calmodulinopathy Registry.
     Eur Heart J. 2023;44:3357-3370.
     PubMed     Abstract available
     
     
     
268. MOHANTY S, La Fazia VM, Natale A
     The Antwerp score: is this the 'new hope on the horizon'?
     Eur Heart J. 2023;44:3336-3338.
     PubMed    
     
     
     
269. GONG X, Liu JX, Huang XB
     Surgical removal of acoustic neuroma eliminates sick sinus syndrome.
     Eur Heart J. 2023;44:3388.
     PubMed    
     
     
     
270. COURT-KOWALSKI S, McArthur A, Hayres K
     Pulsus paradoxus, electrical alternans, and pulsus alternans in progressive cardiac tamponade.
     Eur Heart J. 2023;44:3297.
     PubMed    
     
     
     
271. MIDDELDORP ME, Sandhu RK
     The stroke enigma: decoding the sex risk factor in atrial fibrillation.
     Eur Heart J. 2023 Sep 6:ehad531. doi: 10.1093.
     PubMed    
     
     
     August 2023
272. ESSAYAGH B, Sabbag A, El-Am E, Cavalcante JL, et al
     Arrhythmic mitral valve prolapse and mitral annular disjunction: pathophysiology, risk stratification, and management.
     Eur Heart J. 2023 Aug 10:ehad491. doi: 10.1093.
     PubMed     Abstract available
     
     
     April 2023
273. LEE J, Kim JS, Shim CY
     MitraClip single-leaflet detachment and consequent migration in atrial functional mitral regurgitation.
     Eur Heart J. 2023 Apr 26:ehad249. doi: 10.1093.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum